Patient#	Sample#	AGT:(AGT, protein),	ATF-5:(ATF-5, protein),	EGR1:(EGR1, protein),(Halofuginone, active),	ITGA1:(ITGA1, protein),	PTP4A2:(PTP4A2, protein),	SRC:(SRC, protein),	TUBA1B:(TUBA1B, protein),	ERK1-2:(ERK1-2, protein),	PRL-2 /Rab GGTase beta:(PTP4A2, active),(Rab GGTase beta/Rab GGTase alpha, active),	PTP4A3:(PTP4A3, protein),	RABGGTA:(PTP4A2, active),(RABGGTA, protein),(Rab GGTase beta/Rab GGTase alpha, active),	Ca2+:(AGT, active),(PTP4A3, active),	PRL-3/alpha Tubulin:(PTP4A3, active),(TUBA1B, active),	beta1 Integrin:(PTP4A3, active),(beta1 Integrin, protein),	p130 Cas:(PTP4A3, active),(p130 Cas, protein),	ERK1-2-active:(ERK1-2, active),(ERK1-2-active, protein),(PTP4A3, active),	PRL-3/alpha1 Integrin:(ITGA1, active),(PTP4A3, active),	PTP4A1:(PTP4A1, protein),(SRC, active),	CCNA2:(CCNA2, protein),(PTP4A1, active),	CDKN1A:(CDKN1A, protein),(PTP4A1, active),(PTP4A2, active),	PRL-1/ATF-5:(ATF-5, active),(PTP4A1, active),	PRL-1/alpha Tubulin:(PTP4A1, active),(TUBA1B, active),	RAC1:(PTP4A1, active),(PTP4A3, active),(RAC1, protein),	RHOA:(PTP4A1, active),(PTP4A3, active),(RHOA, protein),	RHOC:(PTP4A1, active),(PTP4A3, active),(RHOC, protein),	mitosis:(PTP4A1, active),	CDK2/Cyclin E1:(CDKN1A, active),	ROCK1:(RHOA, active),(RHOC, active),(ROCK1, protein),	G1/S transition of mitotic cell cycle:(CCNA2, active),(CDK2/Cyclin E1, active),	cell motility:(ROCK1, active),	
